Skip to main content
    M

    Medirom Healthcare Technologies Inc (MRM)

    Official site

    CONSUMER CYCLICAL • PERSONAL SERVICES • NASDAQ

    $0.28
    +0.00 (+1.16%)

    Market Cap: $2.19M

    Last updated: Nov 17, 2026 at 10:26 AM ET

    Medirom Healthcare Technologies Inc (MRM) Financials: Revenue, Profit and Cash Flow

    Updated Mar 31, 2026. Financial statements from company filings, amounts in JPY.

    Medirom Healthcare Technologies reported revenue of JPY 4.04M for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was JPY 374.72K with a net margin of 9.3%. The quarter ended Mar 31, 2026 had revenue of JPY 611.99M and net income of JPY 63.43M.

    Revenue and Margins

    The operating margin was 10.3% in the fiscal year ended Dec 2025, the highest of the 8 years shown. Over the 7 years to Dec 2025, revenue fell from JPY 3.43B, a compound annual decline of 61.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 20254.04M-100.0%96.6%10.3%9.3%
    Dec 20248.30B+21.5%27.1%-0.2%1.8%
    Dec 20236.83B-1.8%23.0%-5.7%1.7%
    Dec 20226.95B+28.5%27.4%1.4%2.1%
    Dec 20215.41B+61.9%26.2%-7.0%-18.3%
    Dec 20203.34B-14.5%12.8%-22.3%-16.1%
    Dec 20193.91B+13.8%24.3%0.9%0.4%
    Dec 20183.43BN/A27.9%2.1%1.9%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 99.7% from the year before. In the quarter ended Mar 2026, net income fell 91.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue4.04M8.30B6.83B6.95B5.41B3.34B3.91B3.43B
    Cost of revenue137.79K6.05B5.26B5.05B3.99B2.91B2.96B2.48B
    Gross profit3.90M2.25B1.57B1.90B1.42B428.95M950.76M956.87M
    Research and development0000013.47M00
    Operating income414.31K-18.10M-391.58M96.97M-379.53M-746.09M34.35M73.27M
    Net income374.72K148.76M115.05M148.97M-990.73M-539.17M17.34M66.31M
    EBITDA513.79K387.50M310.08M373.63M-228.07M-551.16M125.07M158.31M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Revenue611.99M611.99M3.15B3.15B4.82B4.82B3.48B3.48B3.59B3.59B3.24B3.24B
    Gross profit609.86M609.86M341.53M341.53M1.67B1.67B576.56M576.56M889.91M889.91M678.96M678.96M
    Operating income70.63M70.63M-814.63M-814.63M618.57M618.57M-636.67M-636.67M-81.32M-81.32M-310.26M-310.26M
    Net income63.43M63.43M-671.06M-671.06M730.94M730.94M-582.18M-582.18M470.47M470.47M-355.07M-355.07M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, short-term debt of JPY 1.74B exceeded cash and equivalents by 1.72B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets4.16B8.09B6.85B6.75B5.75B5.71B4.76B4.52B
    Current assets3.57B2.71B1.76B2.36B1.38B2.09B1.38B934.04M
    Cash and equivalents20.14M329.40M106.35M605.45M370.62M1.44B513.62M211.69M
    Total liabilities2.82B6.90B6.63B6.81B5.96B5.22B4.16B4.64B
    Short-term debt1.74B1.91B1.26B868.94M917.47M900.60M1.08B1.18B
    Long-term debtN/A764.20M1.05B1.15B746.59M668.38M150.53M342.77M
    Shareholder equity1.33B933.27M210.88M-59.38M-208.34M491.26M600.06M-117.56M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total assets4.16B4.16B7.98B7.98B8.09B8.09B5.83B5.83B6.85B6.85B6.06B6.06B
    Total liabilities2.82B2.82B7.49B7.49B6.90B6.90B6.19B6.19B6.63B6.63B6.47B6.47B
    Cash and equivalents20.14M20.14M32.62M32.62M329.40M329.40M144.65M144.65M106.35M106.35M117.73M117.73M
    Shareholder equity1.33B1.33B442.34M442.34M933.27M933.27M-363.20M-363.20M210.88M210.88M-414.44M-414.44M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-1.33B-631.74M-685.70M-557.23M-366.42M7.87M141.87M
    Capital expenditures564.81M135.84M120.74M113.78M73.56M7.41M34.30M
    Free cash flow-1.90B-767.58M-806.44M-671.01M-439.98M464.00K107.57M
    Investing cash flow361.39M-328.58M580.44M-83.94M-139.60M-37.93M-79.39M
    Financing cash flow1.19B461.21M340.10M-427.95M1.43B331.99M-74.47M
    Fiscal years ended Dec 2018 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-342.02M-342.02M-545.96M-545.96M-831.32M-785.72M27.79M-21.70M-610.04M-610.04M-335.14MN/A
    Capital expenditures16.02M16.02M546.12M546.12M18.70M18.70M79.60M79.60M56.24M56.24M80.37M0
    Free cash flow-358.04M-358.04M-1.09B-1.09B-850.01M-804.41M-51.81M-101.30M-666.28M-666.28M-415.52MN/A
    Last 12 quarters

    Frequently Asked Questions About MRM

    What is Medirom Healthcare Technologies' annual revenue?

    Medirom Healthcare Technologies reported revenue of JPY 4.04M for the fiscal year ended Dec 31, 2025.

    How fast is Medirom Healthcare Technologies' revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -91.7%.

    Is Medirom Healthcare Technologies profitable?

    Yes. Medirom Healthcare Technologies reported net income of JPY 374.72K for the fiscal year ended Dec 31, 2025, with a net margin of 9.3%.

    How much debt does Medirom Healthcare Technologies have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of JPY 1.74B and cash and equivalents of JPY 20.14M.

    What is MRM's profit margin?

    For the fiscal year ended Dec 31, 2025, Medirom Healthcare Technologies reported gross margin of 96.6%, operating margin of 10.3% and net margin of 9.3%.